3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
31
Peritoneal Neoplasms
28
Fallopian Tube Neoplasms
14
Stomach Neoplasms
13
Carcinoma, Ovarian Epithelial
13
Colorectal Neoplasms
11
Appendiceal Neoplasms
5
Neoplasm Metastasis
4
Uterine Neoplasms
3
Recurrence
3
Neoplasms
3
Uterine Cervical Neoplasms
2
Pseudomyxoma Peritonei
2
Pancreatic Neoplasms
2
Mesothelioma, Malignant
2
Mesothelioma
2
Colonic Neoplasms
2
Carcinoma
2
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pleural Effusion
1
Peritoneal Diseases
1
Pelvic Neoplasms
1
Ovarian Epithelial Cancer Recurrent
1
Ovarian Cancer Recurrent
1
Liposarcoma
1
Krukenberg Tumor
1
Hyperthermia
1
Gastrointestinal Neoplasms
1
Interventions
Doxorubicin
6
Ifosfamide
4
Filgrastim
3
belinostat
2
Radiotherapy
2
Imatinib Mesylate
2
sodium thiosulfate
1
saracatinib
1
perifosine
1
brostallicin
1
X-Rays
1
Vincristine
1
Trabectedin
1
Therapeutics
1
Temozolomide
1
Sunitinib
1
Specimen Handling
1
Radiation, Ionizing
1
Quality of Life
1
Platinum
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Mass Spectrometry
1
Magnetic Resonance Spectroscopy
1
Injections
1
Immunotherapy
1
Hyperthermic Intraperitoneal Chemotherapy
1
Fulvestrant
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liposarcoma
×
Hyperthermic Intraperitoneal Chemotherapy
×
Gynecologic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled